These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 21443700)

  • 21. Prevalence of irritable bowel syndrome and functional dyspepsia, overlapping symptoms, and associated factors in a general population of Bangladesh.
    Perveen I; Rahman MM; Saha M; Rahman MM; Hasan MQ
    Indian J Gastroenterol; 2014 May; 33(3):265-73. PubMed ID: 24664445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overlap of symptoms of gastroesophageal reflux disease, dyspepsia and irritable bowel syndrome in the general population.
    Rasmussen S; Jensen TH; Henriksen SL; Haastrup PF; Larsen PV; Søndergaard J; Jarbøl DE
    Scand J Gastroenterol; 2015 Feb; 50(2):162-9. PubMed ID: 25525975
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The epidemiology and quality of life of functional gastrointestinal disorders according to Rome III vs Rome IV criteria: A cross-sectional study in primary care.
    Chuah KH; Beh KH; Mahamad Rappek NA; Mahadeva S
    J Dig Dis; 2021 Mar; 22(3):159-166. PubMed ID: 33595169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discriminant value of Rome III questionnaire in dyspeptic patients.
    Abid S; Siddiqui S; Jafri W
    Saudi J Gastroenterol; 2011; 17(2):129-33. PubMed ID: 21372351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of pancreatic enzyme abnormalities and protease-activated receptor-2-positive eosinophils in the duodenum of patients with functional dyspepsia-irritable bowel syndrome overlap with functional dyspepsia alone in Asian populations.
    Futagami S; Kessoku T; Kasai Y; Higurashi T; Nakajima A; Agawa S; Yamawaki H; Nakamura K; Habiro M; Kawawa R; Ueki N; Higashida S; Watanabe Y; Yamato H; Yamamoto T; Takasaki Y; Ito K; Hojo M; Isayama H; Motoda N; Ohashi R; Siah KTH; Ng CK; Gwee KA
    J Gastroenterol Hepatol; 2023 Oct; 38(10):1778-1786. PubMed ID: 37278449
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Post-infection functional gastrointestinal disorders following coronavirus disease-19: a prospective follow-up cohort study.
    Zhang D; Chen C; Xie Y; Zeng F; Chen S; Chen R; Zhang X; Huang S; Li D; Bai F
    BMC Infect Dis; 2023 Jun; 23(1):422. PubMed ID: 37344782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Population based study: atopy and autoimmune diseases are associated with functional dyspepsia and irritable bowel syndrome, independent of psychological distress.
    Koloski N; Jones M; Walker MM; Veysey M; Zala A; Keely S; Holtmann G; Talley NJ
    Aliment Pharmacol Ther; 2019 Mar; 49(5):546-555. PubMed ID: 30687959
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overlap of Irritable Bowel Syndrome and Functional Dyspepsia in the Clinical Setting: Prevalence and Risk Factors.
    von Wulffen M; Talley NJ; Hammer J; McMaster J; Rich G; Shah A; Koloski N; Kendall BJ; Jones M; Holtmann G
    Dig Dis Sci; 2019 Feb; 64(2):480-486. PubMed ID: 30368683
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of Irritable Bowel Syndrome, Functional Dyspepsia and their Overlap in Bulgaria: a Population-Based Study.
    Nakov R; Dimitrova-Yurukova D; Snegarova V; Uzunova M; Lyutakov I; Ivanova M; Madzharova K; Valkov H; Hristova R; Ivanov K; Kosturkov I; Valcheva G; Nakov N; Nakov V
    J Gastrointestin Liver Dis; 2020 Sep; 29(3):329-338. PubMed ID: 32919417
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frequency and risk factors of functional gastro-intestinal disorders in a rural Indian population.
    Ghoshal UC; Singh R
    J Gastroenterol Hepatol; 2017 Feb; 32(2):378-387. PubMed ID: 27262283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overlap syndrome of functional dyspepsia and irritable bowel syndrome - are both diseases mutually exclusive?
    Suzuki H; Hibi T
    J Neurogastroenterol Motil; 2011 Oct; 17(4):360-5. PubMed ID: 22148104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The spectra, symptom profiles and overlap of Rome III functional gastrointestinal disorders in a tertiary center in South China.
    Xiong LS; Shi Q; Gong XR; Cui Y; Chen MH
    J Dig Dis; 2014 Oct; 15(10):538-44. PubMed ID: 25102919
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decreased Basal and postprandial plasma serotonin levels in patients with functional dyspepsia.
    Cheung CK; Lee YY; Chan Y; Cheong PK; Law WT; Lee SF; Sung JJ; Chan FK; Wu JC
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1125-9. PubMed ID: 23591288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic gastrointestinal symptoms and quality of life in the Korean population.
    Jeong JJ; Choi MG; Cho YS; Lee SG; Oh JH; Park JM; Cho YK; Lee IS; Kim SW; Han SW; Choi KY; Chung IS
    World J Gastroenterol; 2008 Nov; 14(41):6388-94. PubMed ID: 19009657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiology of Functional Gastrointestinal Disorders in Japan and in the World.
    Oshima T; Miwa H
    J Neurogastroenterol Motil; 2015 Jul; 21(3):320-9. PubMed ID: 26095436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validation of the pediatric Rome II criteria for functional gastrointestinal disorders using the questionnaire on pediatric gastrointestinal symptoms.
    Caplan A; Walker L; Rasquin A
    J Pediatr Gastroenterol Nutr; 2005 Sep; 41(3):305-16. PubMed ID: 16131985
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiology of functional gastrointestinal disorders using ROME III adult questionnaire, a population based cross sectional study in Karachi-Pakistan.
    Abid S; Rehman H; Awan S; Artani A; Siddiqui I
    PLoS One; 2022; 17(6):e0268403. PubMed ID: 35696397
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spectra of functional gastrointestinal disorders diagnosed by Rome III integrative questionnaire in a Japanese outpatient office and the impact of overlapping.
    Nakajima S; Takahashi K; Sato J; Fukuda M; Yamamoto K; Inoue T; Okumura Y; Fujiyama Y
    J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S138-43. PubMed ID: 20586856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validation of the Rome III criteria and alarm symptoms for recurrent abdominal pain in children.
    Gijsbers CF; Benninga MA; Schweizer JJ; Kneepkens CM; Vergouwe Y; Büller HA
    J Pediatr Gastroenterol Nutr; 2014 Jun; 58(6):779-85. PubMed ID: 24866784
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rome III functional dyspepsia subdivision in PDS and EPS: recognizing postprandial symptoms reduces overlap.
    Carbone F; Holvoet L; Tack J
    Neurogastroenterol Motil; 2015 Aug; 27(8):1069-74. PubMed ID: 26220647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.